Skip to content
Live From WCLC 2025: Sunday Highlights episode artwork

Sep 7, 2025 24 min

Live From WCLC 2025: Sunday Highlights

from Lung Cancer Considered Hosted by IASLC

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we all were waiting for the FLAURA-2 overall survival. Dr. Alexander Drilon shares results from the ARROS-1 study including efficacy results and safety data for zidesamtinib, a new ROS1 inhibitor that could change the landscape in the ROS1 space.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Live From WCLC 2025: Sunday Highlights

0:00 24:29

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 24 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on September 7, 2025.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.